Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM6HKEC)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
nor-Binaltorphimine dihydrochloride; nor-BNI dihydrochloride; Norbinaltorphimine dihydrochloride; 105618-26-6; EU-0100806; 113158-34-2; CHEMBL2374078; MolPort-003-958-934; Tox21_500806; MFCD00069374; AKOS024457633; LP00806; NCGC00261491-01; NCGC00094139-01; nor-Binaltorphimine dihydrochloride, solid; HY-100903; CS-0020573; N 1771; SR-01000597959; SR-01000075482; SR-01000597959-1; SR-01000075482-1; J-001459
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||